Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neoepitopes expressed by immune complexes.

P L Amlot1

  • 1Department of Immunology, Royal Free Hospital School of Medicine, London, UK.

Complement and Inflammation
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peripheral lymphocyte subsets in the management of PTLD.

Transplantation proceedings·2002
Same author

A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrin.

Alimentary pharmacology & therapeutics·2002
Same author

Restoring cellular differentiatin in posttransplant lymphoproliferative disease.

Transplantation·2002
Same author

Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells.

Transplantation·2001
Same author

A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn's disease.

Gastroenterology·2001
Same author

Somatically mutated regions of immunoglobulin on human B-cell lymphomas code for peptides that bind to autologous major histocompatibility complex class I, providing a potential target for cytotoxic T cells.

Cancer research·2001
Same journal

Computer-assisted kinetic assay for quantification of total complement activity.

Complement and inflammation·1991
Same journal

HLA complement markers in Italian narcoleptic patients with special emphasis on BfF subtyping.

Complement and inflammation·1991
Same journal

Sarcoidosis and major histocompatibility complex genes with special emphasis on BF F subtypes.

Complement and inflammation·1991
Same journal

Clinical manifestations in humans of combined C7 and C4 deficiency associated with low levels of C2, C8, and C9.

Complement and inflammation·1991
Same journal

Biomedical polymers differ in their capacity to activate complement.

Complement and inflammation·1991
Same journal

Bibliography of complement research for 1989.

Complement and inflammation·1991
See all related articles

Monoclonal antibodies targeting neoepitopes on complement component C3 improve immune complex (IC) detection and isolation. These antibodies offer enhanced specificity and aid in studying C3 metabolism in vivo.

Area of Science:

  • Immunology
  • Biochemistry
  • Clinical Diagnostics

Background:

  • Immune complexes (IC) are crucial in various physiological and pathological processes.
  • Traditional methods for IC detection and isolation often rely on non-specific components like Immunoglobulin, C1q, and C3.
  • These non-specific methods can be prone to interference and spurious interactions.

Purpose of the Study:

  • To review the impact of antibodies targeting neoepitopes on immune complexes (IC).
  • To highlight the advantages of using such antibodies for IC detection and isolation.
  • To explore the potential of these antibodies in analyzing in vivo C3 metabolism.

Main Methods:

  • Review of existing literature on antibodies reacting with neoepitopes on IC.
  • Focus on monoclonal antibodies (MoAbs) recognizing neoepitopes of complement component C3.

Related Experiment Videos

  • Discussion of how these MoAbs facilitate IC assays and isolation.

    • Main Results:

    • Monoclonal antibodies (MoAbs) recognizing C3 neoepitopes significantly enhance IC detection and isolation.
    • These MoAbs provide greater specificity, reducing interference and spurious interactions in assays.
    • Recognition of neoepitopes at different C3 degradation stages allows for in vivo C3 metabolism analysis.

    Conclusions:

    • Antibodies targeting C3 neoepitopes represent a significant advancement in IC detection and isolation techniques.
    • Their specificity and ability to differentiate C3 degradation stages offer new avenues for research.
    • These tools can potentially improve the understanding of human in vivo C3 metabolism related to IC.